SAN DIEGO, Dec. 5, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company generated the largest-ever (unaudited) revenue month in its history in November of 2017.
“We have experienced tremendous growth this year and breaking our sales record in November (pre-audit numbers) yet again only further illustrates the positive trajectory of the company’s overall sales,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “I am confident that we are on track for our best ever revenue-producing year and good momentum to carry forward into 2018.”
The Company recently announced 2017 third-quarter financial results showing a gross revenue increase of over 200% with November 2017 being the third time the Company has broken their monthly sales record just this year.
“The recent growth experienced by the portfolio of companies is so exciting and beyond expectations,” said Medical Marijuana, Inc. Chief Operating Officer, Blake Schroeder. “Revenue has grown multiple times over the past 18 months with no signs of slowing down anytime soon.”
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER AND DISCLOSURES
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
The statements in this press release have not been evaluated by the Food and Drug Administration (FDA) and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.
Public Relations Contact:
Chief Executive Officer
P: 888-829- 0070